Adults referred to the commercial weight loss programme Weight Watchers shed twice as much weight as people who received standard care over a 12-month period, according to a new study. In clinical trials, researchers led by Susan Jebb of the UK Medical Research Council assessed 772 overweight and obese adults in Australia, Germany, and Britain. About half the patients received a year's standard care, while the other half were given a 12-month free membership for a Weight Watchers group near their homes. Sixty-one percent of the participants assigned to the commercial programme completed it, while 51 percent of the "standard care" group finished their programme. Overall, individuals in Weight Watchers lost around twice as much weight as did those in the other group, a mean loss of 5.1 kilograms versus 2.2. Among those who stuck with either programme to the end, the figures were 6.7 against. 3.3 kg respectively. Participants randomised to Weight Watchers were also more than three times as likely to lose at least five percent of their bodyweight. Weight Watchers offers weekly weighing and group support. It also promotes a balanced, reduced-energy diet along with increased physical activity. Primary care providers -- sometimes nurses, sometimes doctors -- generally offer weight-loss treatment in line with national guidelines, but vary in the level of supervision. "The similar weight losses achieved in Australia, Germany, and the UK implies that this commercial programme, in partnership with primary care providers, is a robust intervention that is generalisable to other economically developed countries," the researchers concluded. The researchers emphasised the important role of family doctors and primary health-care providers in providing advice, and in making referrals to commercial weight-loss programmes. "Further research is needed to examine long-term weight loss maintenance, together with a formal analysis of cost-effectiveness," they added.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkillerMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor